New study increases understanding of HIV drug's negative effects on the brain
Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...
KUOW5d
This preventive drug could be a 'game changer' in ending the HIV epidemic
In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating ...
ThePrint on MSN4d
Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...
newsbytesapp.com4d
Meet Lenacapavir: The drug that could end HIV epidemic
Potential to revolutionize HIV prevention. Ethel Weld, an Assistant Professor of Medicine at Johns Hopkins University School ...
Deccan Herald5d
Activists to oppose pharma major’s patent claims on new HIV drug
New Delhi: Indian public health campaigners on Wednesday said they will oppose the patent applications of a promising new but ...
Doctor Retracts Claim That You Can Catch HIV From Toilet Paper
Nobody has ever contracted HIV or hepatitis from toilet roll, as the viruses don't survive for long outside the body.
Boise State Public Radio3d
Ukraine keeps up the fight against HIV while fighting a war
Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...
Indiatimes4d
Public health groups raise concern on patent grant to promising, new HIV drug
The HIV drug which costs around $44,000 for twice-yearly ... Worldwide there are 1.3 million infections every year, with one new HIV infection every 24 seconds. Gilead has several patent ...
GlobalData on MSN6d
Gilead’s lenacapavir: HIV prospects strongest in long-acting combos with Merck’s islatravir
Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...
STAT4d
Tested in Africa, used in America
Drug companies typically only ensure drug access ... industry to grant permission for access while tens of thousands of new HIV infections accrue? In principle, solutions to enable access are ...